# Feature Specification: Protein Sequence Analysis

**Feature Branch**: `001-protein-sequence-analysis`

**Created**: 2026-10-20

**Status**: Draft

**Input**: User description: Create a user-facing protein sequence analysis application based on the aggregated test cases in `scratch/test_protein_sequence_analyzer.txt`.

## User Scenarios & Testing

### User Story 1 - Analyze and Validate a Protein Sequence (Priority: P1)

As a researcher or student, I want to enter a protein sequence or FASTA record and receive trustworthy sequence-level measurements so that I can quickly understand the protein's basic properties.

**Why this priority**: Core analysis is the minimum useful product and establishes the validated, reproducible data used by every other capability.

**Independent Test**: Enter valid raw, FASTA, lowercase, whitespace-containing, single-residue, and long sequences; confirm correct metrics. Enter empty and unsupported input; confirm clear validation without misleading results.

**Acceptance Scenarios**:

1. **Given** the analyzer is open, **when** the user enters a valid raw amino-acid sequence and selects Analyze, **then** the application displays length, molecular weight, theoretical pI, hydrophobicity, composition, and a residue visualization with clear labels and units.
2. **Given** the user enters a FASTA record, **when** the user analyzes it, **then** the header is excluded from calculations and the sequence is analyzed as the equivalent raw sequence.
3. **Given** a valid sequence is entered with lowercase letters and permitted whitespace, **when** it is analyzed, **then** normalization succeeds and produces the same results as the equivalent uppercase sequence.
4. **Given** the sequence is empty or contains unsupported characters, **when** the user selects Analyze, **then** a corrective validation message identifies the problem and no current-looking metrics are produced.
5. **Given** a valid sequence has been analyzed, **when** the user changes it to invalid input, **then** the edited input is preserved and previous results are either marked stale or clearly separated from the failed analysis.
6. **Given** the same valid sequence is analyzed twice, **when** the user compares both results, **then** all displayed values are identical and no duplicate or conflicting result state appears.
7. **Given** user-provided text includes markup-like content, **when** the user submits it, **then** it is treated as input text and cannot execute or alter the application.

### User Story 2 - Interpret Biological Features (Priority: P2)

As a researcher, I want biological feature predictions with evidence and limitations so that I can form hypotheses without confusing predictions with confirmed findings.

**Why this priority**: Predictions add biological value beyond arithmetic sequence properties, but they depend on the validated core analysis experience.

**Independent Test**: Analyze representative sequences containing signal peptides, transmembrane regions, motifs, low-complexity regions, and secondary-structure patterns; verify positions, labels, provenance, and uncertainty. Simulate prediction failure and confirm core metrics remain usable.

**Acceptance Scenarios**:

1. **Given** signal-peptide prediction is available and a sequence has a likely hydrophobic N-terminal signal region, **when** the user analyzes it, **then** the predicted region and residue range are shown with method, source, confidence, and limitations.
2. **Given** a sequence contains a likely membrane-spanning segment, **when** the user requests transmembrane prediction, **then** the region and start/end positions are shown as a prediction rather than experimental confirmation.
3. **Given** a sequence does not provide strong evidence for a supported feature, **when** the user analyzes it, **then** the application reports that no strong prediction was found rather than inventing a feature.
4. **Given** a known motif or domain is found, **when** the user reviews the result, **then** its name, positions, source, and confidence or score are displayed.
5. **Given** a low-complexity, disorder-prone, or secondary-structure region is predicted, **when** the user reviews the visualization, **then** the region is highlighted with a text-based legend and labeled as a prediction.
6. **Given** a prediction service is unavailable or fails, **when** the user requests a prediction, **then** the application shows a clear failure or retry state while retaining available core metrics and never presenting the failed prediction as valid.
7. **Given** a prediction is available, **when** the user opens its details, **then** the method, source or model, version, score or confidence, and limitations are visible.

### User Story 3 - Compare, Discover, and Report on Proteins (Priority: P2)

As a researcher, I want to compare saved sequences, align them, search protein records, and export results so that I can investigate relationships and share reproducible findings.

**Why this priority**: Comparison and discovery support real analysis workflows after individual sequences have been characterized.

**Independent Test**: Save two or more valid sequences, compare them, run pairwise and multiple-sequence alignment, search for records, filter the library, and export a report. Verify correct empty, missing-metadata, and no-match states.

**Acceptance Scenarios**:

1. **Given** two valid sequences are saved, **when** the user selects them for comparison, **then** both appear side by side and supported metrics and differences are clearly labeled without relying only on color.
2. **Given** two sequences of different lengths are available, **when** the user runs pairwise alignment, **then** matches, mismatches, insertions, deletions, positions, scoring assumptions, and gap assumptions are available.
3. **Given** at least three valid sequences are available, **when** the user runs multiple-sequence alignment, **then** all selected sequences are labeled, aligned, and comparable at conserved positions.
4. **Given** an accession or valid sequence and an available database search, **when** the user searches, **then** matching records show name, accession, organism, length, source, and retrieval time without losing the current analysis.
5. **Given** a search has no known match, **when** it completes, **then** a clear no-results state allows the user to revise the search or return to analysis.
6. **Given** the saved library contains different names, accessions, and types, **when** the user searches and filters it, **then** rows update correctly, empty results are explained, and clearing filters restores the library.
7. **Given** a saved sequence lacks optional metadata, **when** it is compared, **then** missing values are shown as unavailable and supported comparisons continue to work.
8. **Given** a comparison or alignment is complete, **when** the user exports a report, **then** it includes identifiers or sequences, methods, settings, results, and analysis version, and matches the displayed values.

### User Story 4 - Use the Analyzer Accessibly and Reliably (Priority: P1)

As any application user, including users on mobile devices or using assistive technology, I want the analyzer to be understandable, responsive, and recoverable so that I can complete analysis without losing work.

**Why this priority**: Accessibility, clear states, and reliable interaction are required for every user story and are central to trustworthy scientific software.

**Independent Test**: Navigate the application by keyboard, inspect accessible labels and status updates, use mobile and desktop widths, load samples, navigate sections, trigger a delayed operation and retry, and download a report.

**Acceptance Scenarios**:

1. **Given** sample sequences are available, **when** the user selects one, **then** it loads into the input with a clear status and is ready for analysis according to the interface.
2. **Given** the application is open, **when** the user navigates between analysis, saved sequences, comparison, reports, and preferences, **then** the active section is clear and current work is not unexpectedly discarded.
3. **Given** the user relies on a keyboard, **when** they tab through the application and activate controls with Enter or Space, **then** every essential control is reachable in logical order and focus is visible.
4. **Given** the user inspects the application with assistive technology, **when** they review controls, charts, validation messages, and result regions, **then** meaningful labels, status updates, text alternatives, and non-color cues are available.
5. **Given** the application is viewed at narrow mobile and wide desktop widths, **when** the user analyzes a sequence, **then** core input and results remain readable, usable, and free from unintended overlap or clipping.
6. **Given** analysis or prediction takes measurable time, **when** the user starts it, it fails, and retries, **then** progress, failure, and retry states are clear and duplicate submissions are handled safely.
7. **Given** a valid sequence has been analyzed, **when** the user downloads a report, **then** the file has a meaningful name and includes the input or identifier, normalized sequence, results, visualizations or tables, methods, assumptions, and limitations.
8. **Given** a sequence is entered and analyzed, **when** the user navigates, downloads, or performs supported refresh-safe actions, **then** retained state is preserved or the application clearly explains what cannot be restored.
9. **Given** a long sequence is pasted or edited repeatedly, **when** the user types, deletes, or pastes, **then** the interface remains responsive and expensive analysis is not triggered unnecessarily.

### Edge Cases

- Empty input must receive a corrective message and must not produce default or plausible-looking metrics.
- Unsupported residues, digits, punctuation, markup-like content, and malformed FASTA input must not be analyzed as valid protein data.
- A one-residue sequence must calculate without division-by-zero, peptide-bond, or display errors.
- Sequences of at least 1,000 valid residues must complete without crashing, freezing, or uncontrolled visualization overflow.
- A failed prediction must not erase available core metrics or appear as a successful prediction.
- No-match searches must not display unrelated records as matches.
- Missing optional metadata must be displayed as unavailable rather than causing comparison failure.
- Long alignments, tables, and sequences must remain readable through intentional scrolling or responsive treatment.
- Results must remain clearly labeled as current, stale, unavailable, estimated, predicted, or confirmed where applicable.

## Requirements

### Functional Requirements

- **FR-001**: The application MUST accept raw amino-acid sequences and FASTA records.
- **FR-002**: The application MUST preserve the original user input when it displays a normalized analysis sequence separately.
- **FR-003**: The application MUST normalize permitted case and whitespace before analysis.
- **FR-004**: The application MUST reject empty, malformed, and unsupported-residue input with a specific corrective message.
- **FR-005**: The application MUST prevent invalid input from producing plausible-looking current metrics.
- **FR-006**: The application MUST calculate and display sequence length, molecular weight, theoretical pI, hydrophobicity, amino-acid composition, and residue-level visualization for valid sequences.
- **FR-007**: The application MUST calculate valid single-residue sequences and representative long sequences without crashing or uncontrolled layout overflow.
- **FR-008**: The application MUST produce identical displayed results for identical analysis inputs under the same analysis version.
- **FR-009**: The application MUST ensure composition categories account for every residue exactly once and sum to sequence length.
- **FR-010**: The application MUST render user-provided sequence text safely as data and prevent it from executing markup or scripts.
- **FR-011**: The application MUST identify supported signal peptides, transmembrane regions, motifs, domains, low-complexity or disordered regions, and secondary-structure features when evidence and prediction support are available.
- **FR-012**: The application MUST show prediction positions, labels, methods or sources, confidence or scores where available, versions, and limitations.
- **FR-013**: The application MUST distinguish calculated facts and predictions from experimentally confirmed findings.
- **FR-014**: The application MUST report when evidence is insufficient instead of inventing a biological feature.
- **FR-015**: The application MUST show prediction loading, failure, and retry states without hiding successfully computed core metrics.
- **FR-016**: The application MUST allow users to save valid sequences and compare at least two saved sequences side by side.
- **FR-017**: The application MUST support pairwise alignment and show matches, mismatches, insertions, deletions, positions, scoring assumptions, and gap assumptions.
- **FR-018**: The application MUST support multiple-sequence alignment for at least three valid sequences and identify conserved positions.
- **FR-019**: The application MUST allow users to search an available external protein database by accession or sequence and show source, retrieval time, and relevant record details.
- **FR-020**: The application MUST provide clear no-results states and MUST NOT present unrelated records as matches.
- **FR-021**: The application MUST allow users to search and filter saved sequences by supported names, accessions, and types, with an informative empty state and a way to clear filters.
- **FR-022**: The application MUST continue supported comparisons when optional metadata is unavailable and display unavailable values explicitly.
- **FR-023**: The application MUST export analysis, comparison, and alignment reports containing reproducible inputs or references, methods, settings, results, analysis version, assumptions, and limitations.
- **FR-024**: The application MUST provide sample sequence loading and clear status feedback.
- **FR-025**: The application MUST provide navigation among analysis, saved sequences, comparison, reports, and preferences without unexpectedly discarding current work.
- **FR-026**: The application MUST support complete keyboard operation with logical focus order, visible focus, and keyboard activation of controls.
- **FR-027**: The application MUST provide meaningful accessible names, announced or exposed status changes, text alternatives for visual results, and non-color cues for categories and states.
- **FR-028**: The application MUST keep core input and results usable at narrow mobile and wide desktop viewports.
- **FR-029**: The application MUST communicate progress, prevent or safely handle duplicate submissions, and provide useful recovery actions for delayed or failed operations.
- **FR-030**: The application MUST preserve user input during validation errors and clearly identify whether displayed results are current or stale.
- **FR-031**: The application MUST preserve supported user state during navigation, downloads, and refresh-safe actions, or explain state that cannot be restored.
- **FR-032**: The application MUST remain responsive while users paste and edit representative long sequences and MUST avoid unnecessary repeated expensive analysis.

### Key Entities

- **Protein Sequence**: User-provided raw or FASTA input, normalized sequence, identifier, length, and optional metadata.
- **Sequence Analysis**: Deterministic computed properties, composition groups, residue visualization, analysis version, assumptions, and status.
- **Biological Prediction**: Predicted feature type, residue range, method or source, confidence or score, version, status, and limitations.
- **Saved Protein**: A retained valid sequence with user-visible name, accession, type, metadata, and analysis reference.
- **Alignment or Comparison**: Selected sequences, comparison metrics, aligned positions, differences, conserved positions, scoring assumptions, and result status.
- **Database Match**: External record name, accession, organism, length, source, retrieval time, and match status.
- **Analysis Report**: Exported input or references, normalized sequence, results, visualizations or tables, methods, settings, assumptions, limitations, and analysis version.

## Success Criteria

### Measurable Outcomes

- **SC-001**: 100% of the 38 aggregated test scenarios have a corresponding acceptance scenario or explicit edge-case requirement in this specification.
- **SC-002**: At least 95% of valid representative sequences, including single-residue and 1,000-residue inputs, complete core analysis without an application error or loss of input.
- **SC-003**: 100% of empty, malformed, unsupported, and unsafe-input checks prevent misleading current-looking results and provide a corrective or explanatory state.
- **SC-004**: Repeated analysis of the same input produces identical displayed core metrics in 100% of repeatability checks for the same analysis version.
- **SC-005**: Users can complete the primary flow from sequence entry through core results and report download using keyboard-only interaction, with no essential step requiring a pointer.
- **SC-006**: At least 95% of usability checks across narrow mobile and wide desktop viewports show no clipped core result, unintended overlap, or loss of entered data.
- **SC-007**: 100% of failed prediction, no-match search, missing-metadata, and validation-error scenarios display an explicit state rather than a silent or success-shaped fallback.
- **SC-008**: At least 90% of representative users can enter a valid sequence, interpret the core metrics, and identify which outputs are predictions without assistance.
- **SC-009**: Every exported report in validation includes sufficient input, method, result, assumption, limitation, and version information to reproduce or audit the displayed outcome.

## Assumptions

- Users are researchers, students, educators, or other people who understand basic protein-sequence concepts or can use the application's explanations.
- The initial product focuses on sequence-level analysis and interpretation; experimental validation, structure determination, and clinical diagnosis are out of scope.
- External database and prediction searches may be unavailable; the application must expose that state and retain local results.
- A valid protein alphabet and permitted FASTA conventions will be defined consistently across validation, analysis, comparison, and export.
- Saved sequences and supported user state are retained according to the application's normal storage policy; the specification does not require accounts or cross-device synchronization.
- Reports are intended for research and educational use and must state that predictions and computed values do not replace experimental confirmation.
- Standard modern browser interaction, stable connectivity for external discovery, and representative mobile and desktop viewport testing are available.
